Home > Insider Trading > Filing (0001292660-13-000001)

Filing Details

Accession Number:: 0001292660-13-000001
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-02-26 18:11:20
Reporting Period:: 2013-02-22

Filing Date:: 2013-02-26
Accepted Time:: 2013-02-26 18:11:20
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1091596	Cytomedix Inc	CMXI	Surgical & Medical Instruments & Apparatus (3841)	232958959

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1292660	S Richard Kent	C/O Intersouth Partners 406 Blackwell Street, Suite 200 Durham NC 27701		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-02-22	14,042	$0.55	53,934	No	4	P	Indirect	by Intersouth Affiliates V, L.P.
Common Stock	Acquisiton	2013-02-22	307,171	$0.55	1,179,805	No	4	P	Indirect	by Intersouth Partners V, L.P.
Common Stock	Acquisiton	2013-02-22	321,211	$0.55	1,233,738	No	4	P	Indirect	by Intersouth Partners VI, L.P.
Common Stock	Acquisiton	2013-02-22	321,213	$0.55	1,233,740	No	4	P	Indirect	by Intersouth Partners VII, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	by Intersouth Affiliates V, L.P.
No	4	P	Indirect	by Intersouth Partners V, L.P.
No	4	P	Indirect	by Intersouth Partners VI, L.P.
No	4	P	Indirect	by Intersouth Partners VII, L.P.

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant (right to buy)	Acquisiton	2013-02-22	9,829	$0.00	9,829	$0.75
Common Stock	Warrant (right to buy)	Acquisiton	2013-02-22	215,020	$0.00	215,020	$0.75
Common Stock	Warrant (right to buy)	Acquisiton	2013-02-22	224,848	$0.00	224,848	$0.75
Common Stock	Warrant (right to buy)	Acquisiton	2013-02-22	224,849	$0.00	224,849	$0.75

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
9,829	2013-02-22	2018-02-21	No	4	P	Indirect
215,020	2013-02-22	2018-02-21	No	4	P	Indirect
224,848	2013-02-22	2018-02-21	No	4	P	Indirect
224,849	2013-02-22	2018-02-21	No	4	P	Indirect

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Warrant	$1.42	2014-12-31	378,721	378,721	Indirect
Common Stock	Warrant	$1.42	2014-12-31	17,308	17,308	Indirect
Common Stock	Warrant	$1.42	2014-12-31	64,859	64,859	Indirect
Common Stock	Warrant	$1.42	2014-12-31	495,538	495,538	Indirect

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2014-12-31	378,721	378,721	Indirect
2014-12-31	17,308	17,308	Indirect
2014-12-31	64,859	64,859	Indirect
2014-12-31	495,538	495,538	Indirect

Footnotes

The shares of common stock and common stock warrants were acquired on February 22, 2013, in a registered offering of the Issuer's securities pursuant to the effective registration statement on Form S-3 (File No. 333-183704). The Reportable Securities in the above-referenced offering were sold in units, at the price per unit of $0.55, with each unit consisting of one share of common stock together with a warrant to purchase 0.7 of a share of common stock.
The reportable securities are owned directly by Intersouth Affiliates V, L.P. ("AFF V"). The shares directly held by AFF V are indirectly held by Intersouth Associates V, LLC ("ISA V"), as general partner of AFF V, and each of the individual managing members of ISA V. The individual managing members (collectively, the "ISA V Member Managers") of ISA V are Mitch Mumma and Dennis Dougherty. ISA V Member Managers may share voting and dispositive power over the shares directly held by AFF V. Dr. Kent is a member of ISA V, the general partner of AFF V. Dr. Kent disclaims beneficial ownership of these securities and this report is not an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.
The reportable securities are owned directly by Intersouth Partners V, L.P. ("ISP V"). The shares directly held by ISP V are indirectly held by Intersouth Associates V, LLC ("ISA V"), as general partner of ISP V, and each of the individual managing members of ISA V. The individual managing members (collectively, the "ISA V Member Managers") of ISA V are Mitch Mumma and Dennis Dougherty. ISA V Member Managers may share voting and dispositive power over the shares directly held by ISP V. Dr. Kent is a member of ISA V, the general partner of ISP V. Dr. Kent disclaims beneficial ownership of these securities and this report is not an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.
The reportable securities are owned directly by Intersouth Partners VI, L.P. ("ISP VI"). The shares directly held by ISP VI are indirectly held by Intersouth Associates VI, LLC ("ISA VI"), as general partner of ISP VI, and each of the individual managing members of ISA VI. The individual managing members (collectively, the "ISA VI Member Managers") of ISA VI are Mitch Mumma and Dennis Dougherty. ISA VI Member Managers may share voting and dispositive power over the shares directly held by ISP VI. Dr. Kent is a member of ISA VI, the general partner of ISP VI. Dr. Kent disclaims beneficial ownership of these securities and this report is not an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.
The reportable securities are owned directly by Intersouth Partners VII, L.P. ("ISP VII"). The shares directly held by ISP VII are indirectly held by Intersouth Associates VII, LLC ("ISA VII"), as general partner of ISP VII, and each of the individual managing members of ISA VII. The individual managing members (collectively, the "ISA VII Member Managers") of ISA VII are Mitch Mumma and Dennis Dougherty. ISA VII Member Managers may share voting and dispositive power over the shares directly held by ISP VII. Dr. Kent is a member of ISA VII, the general partner of ISP VII. Dr. Kent disclaims beneficial ownership of these securities and this report is not an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.
30% of the warrant is exercisable commencing on February 8, 2012, and the remaining balance of the warrant, upon issuance of the Third Post-Closing Consideration (as defined and set forth in Section 2.4 of the Exchange and Purchase Agreement by and among Cytomedix, Inc., Aldagen, Inc. and Aldagen Holdings, LLC, dated as of February 8, 2012).